Can we avoid TeGenero-like scenarios & be better prepared rather than waiting for dangerous and disastrous outcomes to happen in the clinical phase? We can generate more critical information on drug immune safety in the preclinical phase that could be essential in the success of the drug. Immundnz is constantly working to develop & bring new test systems to analyse drug immune risk. Contact us for immune response & immunogenicity testing. Visit: http://bit.ly/2Oa70O9














